Works matching IS 14741776 AND DT 2014 AND VI 13 AND IP 4

Results: 28

Nanomedicine: Unsticking neutrophils.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 258, doi. 10.1038/nrd4301

By:

Harrison, Charlotte

Publication type:

Article

Obesity and diabetes: Diabetic interactions broken up.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 258, doi. 10.1038/nrd4300

By:

Harrison, Charlotte

Publication type:

Article

Wolfgang Plischke.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 252, doi. 10.1038/nrd4285
Publication type:: Article

Regulators defend incretin drugs.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 247, doi. 10.1038/nrd4307
Publication type:: Article

Neurodegenerative disease: Searching for the weak spots.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 256, doi. 10.1038/nrd4284

By:

Bray, Natasha

Publication type:

Article

Targeting the pancreatic β-cell to treat diabetes.

Published in:

2014

By:

Vetere, Amedeo;
Choudhary, Amit;
Burns, Sean M;
Wagner, Bridget K

Publication type:

journal article

FDA releases first chronic fatigue guidance.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 247, doi. 10.1038/nrd4306
Publication type:: Article

Lyrica survives patent challenge.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 250, doi. 10.1038/nrd4302
Publication type:: Article

Computational chemistry: Targeting microRNA with small molecules.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 258, doi. 10.1038/nrd4298

By:

Harrison, Charlotte

Publication type:

Article

Integrative knowledge management to enhance pharmaceutical R&D.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 239, doi. 10.1038/nrd4290

By:

Marti-Solano, Maria;
Birney, Ewan;
Bril, Antoine;
Pasqua, Oscar Della;
Kitano, Hiroaki;
Mons, Barend;
Xenarios, Ioannis;
Sanz, Ferran

Publication type:

Article

Antibacterial drugs: Redesigned antibiotic combats drug-resistant tuberculosis.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 256, doi. 10.1038/nrd4287

By:

Cully, Megan

Publication type:

Article

US Patent Office issues guidelines on natural product patent eligibility.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 250, doi. 10.1038/nrd4303

By:

Harrison, Charlotte

Publication type:

Article

Immune regulation: IL-35: a new player in B cell activity.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 258, doi. 10.1038/nrd4299

By:

Harrison, Charlotte

Publication type:

Article

Drugging the p53 pathway: understanding the route to clinical efficacy.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 314, doi. 10.1038/nrd4288

By:

Khoo, Kian Hoe;
Verma, Chandra S.;
Lane, David P.

Publication type:

Article

Trial watch: Bone-building antibody outshines current treatments in osteoporosis trial.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 248, doi. 10.1038/nrd4282

By:

Harrison, Charlotte

Publication type:

Article

Thrombotic disorders: Seeking out better anticoagulants.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 255, doi. 10.1038/nrd4292

By:

Harrison, Charlotte

Publication type:

Article

Cancer: Live screening of immunotherapy targets.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 258, doi. 10.1038/nrd4289

By:

Kingwell, Katie

Publication type:

Article

The COPD pipeline.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 253, doi. 10.1038/nrd4254

By:

Mushtaq, Yasser

Publication type:

Article

Schizophrenia drug gets negative results for negative symptoms.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 244, doi. 10.1038/nrd4294

By:

Kingwell, Katie

Publication type:

Article

BioMarin nabs first paediatric priority review voucher.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 247, doi. 10.1038/nrd4305
Publication type:: Article

In this issue.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 237, doi. 10.1038/nrd4291
Publication type:: Article

Recent patents related to aquaporins.

Published in:: Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 251, doi. 10.1038/nrd4304
Publication type:: Article

Drug makers and NIH team up to find and validate targets.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 241, doi. 10.1038/nrd4293

By:

Mullard, Asher

Publication type:

Article

Targeting the pancreatic β-cell to treat diabetes.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 278, doi. 10.1038/nrd4231

By:

Vetere, Amedeo;
Choudhary, Amit;
Burns, Sean M.;
Wagner, Bridget K.

Publication type:

Article

Aquaporins: important but elusive drug targets.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 259, doi. 10.1038/nrd4226

By:

Verkman, Alan S.;
Anderson, Marc O.;
Papadopoulos, Marios C.

Publication type:

Article

Market watch: Upcoming market catalysts in Q2 2014.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 249, doi. 10.1038/nrd4283

By:

Lau, Jolene

Publication type:

Article

Cancer: Unleashing NK cell anti-metastatic activity.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 257, doi. 10.1038/nrd4297

By:

Flemming, Alexandra

Publication type:

Article

Advances in targeting cyclic nucleotide phosphodiesterases.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 4, p. 290, doi. 10.1038/nrd4228

By:

Maurice, Donald H.;
Ke, Hengming;
Ahmad, Faiyaz;
Wang, Yousheng;
Chung, Jay;
Manganiello, Vincent C.

Publication type:

Article